Literature DB >> 2677361

Pathophysiology of vulvovaginal candidiasis.

J D Sobel1.   

Abstract

Women with infrequent episodes of candidal vaginitis frequently have an identifiable cause, but those with chronic and recurrent candidal vaginitis rarely have recognizable precipitating or causal factors. Although an analysis of vaginal yeast isolated from women with recurrent candidal vaginitis reveals a higher percentage of non-albicans species of Candida, resistance to imidazoles is rarely responsible for the recurrent or chronic cases. Strain typing of sequential clinical isolates suggests a pattern of vaginal relapse rather than of frequent vaginal reinfection. Attempts to reduce attacks by treating sexual partners and suppressing a putative gastrointestinal tract focus have failed in the past. The results of immunologic studies suggest the possibility of an acquired Candida antigen-specific immunologic deficiency that results in uncontrolled vaginal Candida proliferation and, hence, repeated clinical attacks. The recent report of normal T-lymphocyte suppression of Candida germ tube production and, hence, inhibition of Candida virulence supports the immunologic hypothesis. Moreover, observations of high-frequency, genetically controlled switching colonies of Candida albicans, accompanied by enhanced virulence and invasive potential of the yeast, may provide an explanation for the recurrent nature of candidal vaginitis in certain women.

Entities:  

Mesh:

Year:  1989        PMID: 2677361

Source DB:  PubMed          Journal:  J Reprod Med        ISSN: 0024-7758            Impact factor:   0.142


  6 in total

1.  Molecular and epidemiological characterization of vaginal Saccharomyces cerevisiae isolates.

Authors:  B Posteraro; M Sanguinetti; G D'Amore; L Masucci; G Morace; G Fadda
Journal:  J Clin Microbiol       Date:  1999-07       Impact factor: 5.948

2.  Immunohistochemical study of in vivo and in vitro IgA coating of candida species in vulvovaginal candidiasis.

Authors:  K Böhler; H Klade; C Poitschek; A Reinthaller
Journal:  Genitourin Med       Date:  1994-06

Review 3.  Evaluation and management of vaginitis.

Authors:  P L Carr; D Felsenstein; R H Friedman
Journal:  J Gen Intern Med       Date:  1998-05       Impact factor: 5.128

4.  Clinical and microbiological characteristics of symptomatic vulvovaginal candidiasis in HIV-seropositive women.

Authors:  A Spinillo; G Michelone; C Cavanna; L Colonna; E Capuzzo; S Nicola
Journal:  Genitourin Med       Date:  1994-08

5.  Zinc levels of serum and cervicovaginal secretion in recurrent vulvovaginal candidiasis.

Authors:  K Böhler; V Meisinger; H Klade; A Reinthaller
Journal:  Genitourin Med       Date:  1994-10

6.  Highly-cited estimates of the cumulative incidence and recurrence of vulvovaginal candidiasis are inadequately documented.

Authors:  Sujit D Rathod; Patricia A Buffler
Journal:  BMC Womens Health       Date:  2014-03-10       Impact factor: 2.809

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.